Introduction: Sudden sensorineural hearing loss (SSNHL) is one of the most controversial subjects in domain of otolaryngology. In this prospective study, we have analyzed clinical features, audiological characteristics, and results of treatment with two routine treatment modalities(oral steroid + acyclovir vs intravenous urografin) in 53 cases with SSNHL.Methods: In 53 patients with chief complaint of SSNHL, after physical examination and audiological evaluation(PTA ,OAE,ABR) ,each patient were included randomly and alternately in one of two treatment modalities and data were analyzed by SPSS software.Results: From 53 cases (M:29 ,F:24) with mean age of 40.9(+/-15.9) years, left ear was involved in 28 cases (52.83%), and right ear in 21 cases (39.62%), and in 4 cases (7.54%) both sides were involved. The severity of hearing loss was "subjectively" high in 78% of patients, and the mean threshold of hearing had been calculated as 69 dB. The most common pattern in pure tone audiometry curves, was flat pattern (75%), and then, downsloping pattern (16%). There were no any difference in response to each of two treatment groups, and 18% of patients responded completely to our treatment, and good response and partial response rate was 12% and 36%, respectively. In 34% of patients, there were no response ,of whom number of cases treated with steroid+acyclovir was more than other modality (11 cases vs. 7). There were no difference in initiating treatment in first 72 hours, before, or after the first week. Patients age and ESR had no significant prognostic role. All patients in whom overall correlation in transient evoked otoacoustic emission (TEOAE), performed before treatment, were more than 50% responded to our treatments. Discussion: SSNHL is one of controversial topics in otolaryngology, and in nearly all of its aspects there are some mysteries to be cleared and perhaps would be necessary to perform a multicenteric study on this subject. Our study results were similar with other studies, although we recommended performing a TEOAE, that would help in determining prognosis of response to treatment.